RU 486 HEARING PLANNED BY REP. WYDEN FOR MAY 16
Executive Summary
RU 486 HEARING PLANNED BY REP. WYDEN FOR MAY 16 before the House Small Business/Regulation Subcommittee. FDA Commissioner Kessler is expected to testify at the hearing, along with representatives from the Population Council, which is working to bring the oral abortifacient drug mifepristone to the U.S., and the German firm Hoechst, which holds a controlling stake in RU 486 manufacturer Roussel Uclaf.